This study could be life-changing for cancer survivors.
Cord blood stem cells have now been shown to reduce neutropenia after chemotherapy, lowering the risk of infection in patients receiving chemo.
WHAT IS NEUTROPENIA?
Sufferers of neutropenia have low levels of neutrophils. These are a type of white blood cell that fights infection by destroying harmful bacteria. People with neutropenia are more likely to develop infections.
NEUTROPENIA AND CHEMOTHERAPY
The horrible twist in the tail of chemo is that beneficial cells are also destroyed. For this reason, around half of those with cancer who receive chemotherapy will also develop neutropenia.
LIFE WITH NEUTROPENIA
Neutropenia sufferers are likely to feel fatigued and to develop severe complications from minor infections.
OTHER CAUSES OF NEUTROPENIA
– Cancers directly affecting the bone marrow, where neutrophils are made, such as leukaemia, lymphoma and myeloma
– Cancers that have spread
– Radiation therapy
– A lowered immune system caused by HIV, infection or organ transplantation
Cord blood is the blood left in the umbilical cord and placenta after birth. It contains stem cells that can treat over 80 diseases of the blood and immune system. Donating or privately storing your baby’s cord blood means that they could be a little life-saver.
BSc (Hons) Microbiology
Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.